Albumin infusion to reduce complications after gastric cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial tests whether giving albumin (a protein in the blood) during and after surgery can help prevent complications in people with stomach cancer. It is for those who have surgery to remove their tumor and have normal or near-normal blood albumin levels before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old and have stomach cancer confirmed by biopsy.
- Your cancer is stage I to III (has not spread to distant organs) and you will have surgery to remove it.
- Your blood albumin level is 30 g/L or higher, and your nutritional risk score is low (NRS-2002 score ≤ 2).
- You are in generally good health (ASA class I-III, ECOG score 0-2) and have no serious heart, lung, liver, or kidney disease.
- You have not had chemotherapy or radiation before surgery, and you are not on long-term immunosuppressants or have HIV.
- You have no known allergy to albumin, and you do not need to have other organs removed during surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a protein called albumin to standard fluids given during surgery helps patients with advanced cancer in the abdomen (from the ovaries, uterus, or digestive system) recover better. You would receive either the usual fluids or fluids plus albumin during your operation.
This trial studies whether doing a structured exercise program and receiving enteral (tube) nutrition after gastric cancer surgery can improve survival. It focuses on people with stage Ib to stage IIIc stomach cancer who have had standard surgery and have not had chemo or radiation before.
This trial looks at protein patterns in the blood of people with stomach cancer. The goal is to find out if these patterns can help guide treatment, especially before surgery. It is for people with a certain type of stomach cancer that has not spread to distant organs.
This trial tests if giving human albumin (a protein fluid) can help treat septic shock in surgical intensive care patients. If you have severe infection and very low blood pressure after surgery, this treatment might improve recovery.
This trial tests a new protein treatment made from rice to help patients recover from low blood protein levels that sometimes occur after liver surgery. The treatment may help your body heal better after the procedure.
This trial tests whether a personalized long-term albumin (a blood protein medicine) can help people with advanced liver scarring who have fluid in the belly (ascites). It compares the personalized albumin approach to standard care to see if it improves outcomes over time.
Hear when a new Postoperative Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.